Literature DB >> 17516082

False negative 17-hydroxyprogesterone screening in children with classical congenital adrenal hyperplasia.

Felix Schreiner1, Christoph Brack, Kirsten Salzgeber, Walburga Vorhoff, Joachim Woelfle, Bettina Gohlke.   

Abstract

We report 5 out of 214 children with classical congenital adrenal hyperplasia (CAH) that was not detected by neonatal 17-Hydroxyprogesterone screening. Therefore, diagnosis was only based on a suspect clinical picture and subsequent re-evaluation. In addition to 3 patients suffering from the simple virilizing form of CAH and not reported so far, the remaining 2 children whose CAH was missed by the screening suffered from the severe salt-wasting form. This report underlines the importance of a careful clinical investigation of newborns to detect signs of genital virilization. The differential diagnosis of classical CAH should be kept in mind even if neonatal screening is reported to be normal.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17516082     DOI: 10.1007/s00431-007-0505-0

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  9 in total

1.  Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  P W Speiser; J Dupont; D Zhu; J Serrat; M Buegeleisen; M T Tusie-Luna; M Lesser; M I New; P C White
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

2.  Virilising 21-hydroxylase deficiency: timing of newborn screening and confirmatory tests can be crucial.

Authors:  K Gudmundsson; J A Majzoub; G Bradwin; S Mandel; N Rifai
Journal:  J Pediatr Endocrinol Metab       Date:  1999 Nov-Dec       Impact factor: 1.634

3.  Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany.

Authors:  N Krone; A Braun; A A Roscher; D Knorr; H P Schwarz
Journal:  J Clin Endocrinol Metab       Date:  2000-03       Impact factor: 5.958

4.  Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia.

Authors:  Felix Votava; Dóra Török; József Kovács; Dorothea Möslinger; Sabina M Baumgartner-Parzer; János Sólyom; Zuzana Pribilincová; Tadej Battelino; Jan Lebl; Herwig Frisch; Franz Waldhauser
Journal:  Eur J Endocrinol       Date:  2005-06       Impact factor: 6.664

5.  Complete virilization in congenital adrenal hyperplasia: clinical course, medical management and disease-related complications.

Authors:  J Woelfle; W Hoepffner; W G Sippell; J H Brämswig; P Heidemann; D Deiss; A Bökenkamp; C Roth; U Irle; H A Wollmann; M Zachmann; K Kubini; N Albers
Journal:  Clin Endocrinol (Oxf)       Date:  2002-02       Impact factor: 3.478

6.  Benefits of neonatal screening for congenital adrenal hyperplasia (21-hydroxylase deficiency) in Sweden.

Authors:  A Thil'en; A Nordenström; L Hagenfeldt; U von Döbeln; C Guthenberg; A Larsson
Journal:  Pediatrics       Date:  1998-04       Impact factor: 7.124

7.  Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia.

Authors:  B L Therrell; S A Berenbaum; V Manter-Kapanke; J Simmank; K Korman; L Prentice; J Gonzalez; S Gunn
Journal:  Pediatrics       Date:  1998-04       Impact factor: 7.124

8.  Pitfall of newborn screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  Tilman R Rohrer; Katja F Gassmann; Marianne E Pavel; Helmuth G Dörr
Journal:  Biol Neonate       Date:  2003

9.  Steroid 21-hydroxylase deficiency: genotype may not predict phenotype.

Authors:  R C Wilson; A B Mercado; K C Cheng; M I New
Journal:  J Clin Endocrinol Metab       Date:  1995-08       Impact factor: 5.958

  9 in total
  4 in total

Review 1.  Genetic screening.

Authors:  Wylie Burke; Beth Tarini; Nancy A Press; James P Evans
Journal:  Epidemiol Rev       Date:  2011-06-27       Impact factor: 6.222

2.  Clinical and environmental influences on metabolic biomarkers collected for newborn screening.

Authors:  Kelli K Ryckman; Stanton L Berberich; Oleg A Shchelochkov; Daniel E Cook; Jeffrey C Murray
Journal:  Clin Biochem       Date:  2012-09-23       Impact factor: 3.281

3.  Lessons learned from 5 years of newborn screening for congenital adrenal hyperplasia in the Czech Republic: 17-hydroxyprogesterone, genotypes, and screening performance.

Authors:  Felix Votava; Dana Novotna; Petr Kracmar; Hana Vinohradska; Eva Stahlova-Hrabincova; Zuzana Vrzalova; David Neumann; Jana Malikova; Jan Lebl; Dietrich Matern
Journal:  Eur J Pediatr       Date:  2012-01-11       Impact factor: 3.183

Review 4.  Biochemical and genetic diagnosis of 21-hydroxylase deficiency.

Authors:  Henrik Falhammar; Anna Wedell; Anna Nordenström
Journal:  Endocrine       Date:  2015-09-04       Impact factor: 3.633

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.